Why you should attend The Digital International Liver Congress™ 2020
Every year, scientific and medical experts from a broad range of fields including hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology, virology, pharmacology, pathology, radiology, and imaging, come together from around the world at the International Liver Congress™ to learn about the latest in liver research. This year, owing to COVID-19 disruptions, the event is being held entirely online, as The Digital International Liver Congress™ 2020.
- ILC is EASL’s annual flagship congress and attracts around 10,000 delegates and 250 media representatives from all over the world
- Specialists share recent data, present studies, and findings
- Discuss the hottest topics on liver disease
- Excellent international networking opportunity
Discover the Digital ILC 2020 scientific programme.
- Get up to speed on the latest in learning, a carefully curated selection of original live and on-demand content from world-renowned experts
- Tap into the Digital ILC 2020 scientific programme of unprecedented global relevance
- Hear and interact with the experts chairing the sessions at Digital ILC 2020
- Learn about the latest science, education, and advances in liver disease therapy
- Stay cutting-edge with a session on the latest on COVID-19 and the liver
- Fine-tune your expertise, following numerous sessions: abstract sessions, poster tours, interactive sessions, industry symposia, and wrap up sessions
- Enjoy exclusive access to the full on-demand content until 31 December 2020 (available exclusively to registered participants of Digital ILC).
- Enjoy easy access from anywhere worldwide, with key presentations just a click away
- Mingle with your peers at the EASL Community Hub
- Benefit from attractive registration rates for EASL members, Young Investigators, nurses & AHPs
- Network with 10,000+ members of this engaged hepatology community
- Connect with industry leaders, participating in industry symposia
- Take part in the online conversation, using #ILC2020 and following us @EASLnews
- Interact directly, putting your questions to leading experts via the interactive digital platform hosting the event
- Share knowledge with your peers and leaders in the field, discussing the latest research and trends
- Share your views, chatting live, including with representatives at exhibitions, industry symposia, EASL staff, partners, and consortia
- Visit EASL’s virtual booths and partner booths including sister societies, national associations
- Become part of our community, signing up as an EASL member and then sharing your expertise with us
The Digital International Liver Congress™ 2020
At the Digital International Liver Congress™ 2020, EASL is turning its attention to health in daily life and its importance in protecting the liver. Doctors, patients and patient groups, allied health professionals, and policymakers will discuss important new insights and information to help combat liver disease.
Attendees will hear the latest epidemiological and real-world data on the latest liver research.
EASL’s principles and values
EASL is committed to furthering research in the field of hepatology to improve the lives of everyone affected by liver disease. The combined efforts of all stakeholders in the public and private sectors and civil society are essential to halting and reversing liver disease. As such, EASL acknowledges that every voice is valued.
EASL embraces freedom of expression at The Digital International Liver Congress™ 2020, as an essential principle in the response to progressing liver disease and in promoting full participation during the congress. However, EASL is responsible for maintaining the safety of all attendees and as such, must balance the need of allowing all participants to be heard while ensuring events are not disrupted.
Please consult the EASL policy statement on equality, diversity, and inclusion.
29 August 2020
As the twin global epidemics of obesity and NAFLD continue to grow, it is more important than ever…
29 August 2020
Since January 2020, the COVID-19 pandemic has not been out of the news. It has overwhelmed countries and…
29 August 2020
This interactive session explored whether precision medicine to manage NAFLD and find new therapies for NAFLD subtypes would…